Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune hepatitis.

Dwain L Thiele1

  • 1Department of Internal Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9151, USA. dwain.thiele@utsouthwestern.edu

Clinics in Liver Disease
|October 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of intrahepatic CD3+/CD4-/CD8- double negative T (DN T) cells in enhanced acetaminophen toxicity.

Toxicology and applied pharmacology·2014
Same author

Tumor necrosis factor receptor 1 expression is upregulated in dendritic cells in patients with chronic HCV who respond to therapy.

Hepatitis research and treatment·2010
Same author

Susceptibility to acetaminophen (APAP) toxicity unexpectedly is decreased during acute viral hepatitis in mice.

Biochemical pharmacology·2009
Same author

Granzyme C supports efficient CTL-mediated killing late in primary alloimmune responses.

Journal of immunology (Baltimore, Md. : 1950)·2008
Same author

Intrahepatic lymphocyte expression of dipeptidyl peptidase I-processed granzyme B and perforin induces hepatocyte expression of serine proteinase inhibitor 6 (Serpinb9/SPI-6).

Journal of immunology (Baltimore, Md. : 1950)·2007
Same author

The role of serpinb9/serine protease inhibitor 6 in preventing granzyme B-dependent hepatotoxicity.

Hepatology (Baltimore, Md.)·2007

Autoimmune hepatitis (AIH) is a chronic liver condition diagnosed by clinical, lab, and histologic features. Treatment involves corticosteroids and immunosuppressants, with most patients requiring long-term management.

Area of Science:

  • Hepatology
  • Immunology
  • Internal Medicine

Background:

  • Autoimmune hepatitis (AIH) is a chronic liver disease.
  • Diagnosis relies on a combination of clinical, laboratory, and histological findings.
  • No single marker definitively identifies AIH.

Purpose of the Study:

  • To summarize the key characteristics of autoimmune hepatitis.
  • To outline diagnostic criteria for AIH.
  • To review current therapeutic strategies and long-term management.

Main Methods:

  • Review of clinical, laboratory, and histological features of AIH.
  • Analysis of treatment responses to corticosteroids and immunosuppressants.
  • Evaluation of long-term outcomes and remission possibilities.

Related Experiment Videos

Main Results:

  • AIH presents with hypergammaglobulinemia, autoantibodies, and periportal hepatitis.
  • Corticosteroids (prednisone/prednisolone) are primary initial treatments.
  • Immunosuppressants like azathioprine aid in steroid-sparing and long-term remission maintenance.

Conclusions:

  • AIH diagnosis requires a comprehensive assessment excluding other liver diseases.
  • Most AIH patients require ongoing immunosuppressive therapy and monitoring.
  • While some achieve remission after treatment withdrawal, AIH is typically a lifelong condition.